Overview

Study to Evaluate the Safety of IMM-01 in Patients With Advanced Solid Tumours

Status:
Not yet recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
A study to assess the safety of IMM-01 in participants with advanced solid tumors
Phase:
Phase 1
Details
Lead Sponsor:
Modulate Therapeutics Ltd
Treatments:
Losartan